Sympathetic activation during early pregnancy in humans

Sympathetic activity has been reported to increase in normotensive pregnant women, and to be even greater in women with gestational hypertension and preeclampsia at term. Whether sympathetic overactivity develops early during pregnancy, remaining high throughout gestation, or whether it only occurs at term providing the substrate for hypertensive disorders is unknown. We tested the hypothesis that sympathetic activation occurs early during pregnancy in humans. Eleven healthy women (29 +/- 3 (SD) years) without prior hypertensive pregnancies were tested during the mid-luteal phase (PRE) and early pregnancy (EARLY; 6.2 +/- 1.2 weeks of gestation). Muscle sympathetic nerve activity (MSNA) and haemodynamics were measured supine, at 30 deg and 60 deg upright tilt for 5 min each. Blood samples were drawn for catecholamines, direct renin, and aldosterone. MSNA was significantly greater during EARLY than PRE (supine: 25 +/- 8 vs. 14 +/- 8 bursts min-1, 60 deg tilt: 49 +/- 14 vs. 40 +/- 10 bursts min-1; main effect, P < 0.05). Resting diastolic pressure trended lower (P= 0.09), heart rate was similar, total peripheral resistance decreased (2172 +/- 364 vs. 2543 +/- 352 dyne s cm-5; P < 0.05), sympathetic vascular transduction was blunted (0.10 +/- 0.05 vs. 0.36 +/- 0.47 units a.u.-1 min-1; P < 0.01), and both renin (supine: 27.9 +/- 6.2 vs. 14.2 +/- 8.7 pg ml-1, P < 0.01) and aldosterone (supine: 16.7 +/- 14.1 vs. 7.7 +/- 6.8 ng ml-1, P= 0.05) were higher during EARLY than PRE. These results suggest that sympathetic activation is a common characteristic of early pregnancy in humans despite reduced diastolic pressure and total peripheral resistance. These observations challenge conventional thinking about blood pressure regulation during pregnancy, showing marked sympathetic activation occurring within the first few weeks of conception, and may provide the substrate for pregnancy induced cardiovascular complications.